Home › Myelofibrosis › Florida › Miami
Pag-aaral pangklinika para sa Myelofibrosis sa Miami, FL
Isang pag-aaral para sa Myelofibrosis ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Miami. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Nagre-recruitPhase 1
- University of Miami, Miami
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Nagre-recruitPhase 3
- Miami NS Ins Baptist Health S FL, Miami
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Nagre-recruitPhase 3
- Bioresearch Partners, Miami
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
Nagre-recruitPhase 1
- Sylvester Comprehensive Cancer Center, Miami
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
Nagre-recruitPhase 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Nagre-recruitPhase 1/2
- Sylvester Cancer Center - U Miami, Miami
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Nagre-recruitPhase 1/2
- University of Miami, Miami
- Baptist Health - Miami Cancer Institute, Miami
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Nagre-recruitPhase 1
- University of Miami Health System, Miami
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Nagre-recruitPhase 2
- University of Miami, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Miami
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Nagre-recruitPhase 3
- University of Miami, Miami
Pag-aaral para sa Myelofibrosis sa ibang lungsod
- New York City, NY21 pag-aaral
- Houston, TX20 pag-aaral
- Boston, MA13 pag-aaral
- Durham, NC13 pag-aaral
- Columbus, OH12 pag-aaral
- Seattle, WA12 pag-aaral
- Tampa, FL11 pag-aaral
- Nashville, TN11 pag-aaral
- Salt Lake City, UT11 pag-aaral
- Ann Arbor, MI10 pag-aaral
- Atlanta, GA10 pag-aaral
- Baldwin Park, CA10 pag-aaral
Iba pang pag-aaral sa Miami
- Kanser sa Suso42 pag-aaral
- Kanser (lahat ng uri)36 pag-aaral
- Non-Small Cell Lung Cancer35 pag-aaral
- Kanser sa Prostate30 pag-aaral
- Obesity28 pag-aaral
- Kanser sa Ovary24 pag-aaral
- Acute Myeloid Leukemia24 pag-aaral
- Overweight23 pag-aaral
- Metastatic Cancer22 pag-aaral
- Multiple Myeloma22 pag-aaral
- Kanser sa Baga22 pag-aaral
- Sakit ni Alzheimer21 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.